ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

April 23, 2004

New Drug Reduces Nausea and Vomiting

October 31, 2003

House Disallows NCI Recision

March 14, 1975

Parkinson Heads Oncology At Amgen

May 2, 2003

Most of NCI’s Increase For Breast Cancer to Fund Grants: Broder

May 21, 1993

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014